Literature DB >> 10396434

Migraine: which triptan?

R C Peatfield1.   

Abstract

A wide variety of drugs are now available for the acute treatment of migraine attacks. Although the new triptans are expensive, clinical trials have shown them to be highly effective, and they are the treatment of choice for disabling attacks unresponsive to cheaper medication. This article discusses the different clinical circumstances in which each preparation may prove the most effective.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10396434     DOI: 10.12968/hosp.1999.60.4.1095

Source DB:  PubMed          Journal:  Hosp Med        ISSN: 1462-3935


  2 in total

Review 1.  Delivery systems for acute migraine medications.

Authors:  I Worthington
Journal:  Can Fam Physician       Date:  2001-02       Impact factor: 3.275

Review 2.  Preclinical neuropharmacology of naratriptan.

Authors:  Geoffrey A Lambert
Journal:  CNS Drug Rev       Date:  2005
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.